Literature DB >> 11988537

A natural product that lowers cholesterol as an antagonist ligand for FXR.

Nancy L Urizar1, Amy B Liverman, D'Nette T Dodds, Frank Valentin Silva, Peter Ordentlich, Yingzhuo Yan, Frank J Gonzalez, Richard A Heyman, David J Mangelsdorf, David D Moore.   

Abstract

Extracts of the resin of the guggul tree (Commiphora mukul) lower LDL (low-density lipoprotein) cholesterol levels in humans. The plant sterol guggulsterone [4,17(20)-pregnadiene-3,16-dione] is the active agent in this extract. We show that guggulsterone is a highly efficacious antagonist of the farnesoid X receptor (FXR), a nuclear hormone receptor that is activated by bile acids. Guggulsterone treatment decreases hepatic cholesterol in wild-type mice fed a high-cholesterol diet but is not effective in FXR-null mice. Thus, we propose that inhibition of FXR activation is the basis for the cholesterol-lowering activity of guggulsterone. Other natural products with specific biologic effects may modulate the activity of FXR or other relatively promiscuous nuclear hormone receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988537     DOI: 10.1126/science.1072891

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  108 in total

Review 1.  A ligand-based approach to understanding selectivity of nuclear hormone receptors PXR, CAR, FXR, LXRalpha, and LXRbeta.

Authors:  Sean Ekins; Leonid Mirny; Erin G Schuetz
Journal:  Pharm Res       Date:  2002-12       Impact factor: 4.200

2.  Expression and activation of the farnesoid X receptor in the vasculature.

Authors:  David Bishop-Bailey; Desmond T Walsh; Timothy D Warner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

3.  Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone.

Authors:  Nilesh M Kalariya; Mohammad Shoeb; Aramati B M Reddy; Min Zhang; Frederik J G M van Kuijk; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

4.  Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury.

Authors:  Jun Pu; Ancai Yuan; Peiren Shan; Erhe Gao; Xiaoliang Wang; Yajing Wang; Wayne Bond Lau; Walter Koch; Xin-Liang Ma; Ben He
Journal:  Eur Heart J       Date:  2012-02-03       Impact factor: 29.983

5.  Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.

Authors:  Zhongsheng Peng; Jiayan Chen; Cinthia B Drachenberg; Jean-Pierre Raufman; Guofeng Xie
Journal:  J Biol Chem       Date:  2019-04-09       Impact factor: 5.157

6.  Rational selection of structurally diverse natural product scaffolds with favorable ADME properties for drug discovery.

Authors:  D S Samiulla; V V Vaidyanathan; P C Arun; G Balan; M Blaze; S Bondre; G Chandrasekhar; A Gadakh; R Kumar; G Kharvi; H O Kim; S Kumar; J A Malikayil; M Moger; M K Mone; P Nagarjuna; C Ogbu; D Pendhalkar; A V S Raja Rao; G Venkateshwar Rao; V K Sarma; S Shaik; G V R Sharma; S Singh; C Sreedhar; R Sonawane; U Timmanna; L W Hardy
Journal:  Mol Divers       Date:  2005       Impact factor: 2.943

Review 7.  Pregnane X receptor and natural products: beyond drug-drug interactions.

Authors:  Jeff L Staudinger; Xunshan Ding; Kristin Lichti
Journal:  Expert Opin Drug Metab Toxicol       Date:  2006-12       Impact factor: 4.481

8.  Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor.

Authors:  Donna D Yu; Wenwei Lin; Barry M Forman; Taosheng Chen
Journal:  Bioorg Med Chem       Date:  2014-04-16       Impact factor: 3.641

9.  Growth inhibition of struvite crystals in the presence of herbal extract Commiphora wightii.

Authors:  C K Chauhan; M J Joshi; A D B Vaidya
Journal:  J Mater Sci Mater Med       Date:  2008-06-21       Impact factor: 3.896

10.  Role of cholesterol pathways in norovirus replication.

Authors:  Kyeong-Ok Chang
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.